The influence of HIF-prolyl hydroxylase-2 during colitis and inflammation-associated colorectal carcinogenesis in mice
The influence of HIF-prolyl hydroxylase-2 during colitis and inflammation-associated colorectal carcinogenesis in mice
批准号:
244552708
负责人:
Professor Dr. Ben Wielockx, Ph.D.
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Inflammatory bowel disease (IBD) is a disorder with severe pathology and limited therapeutic options. Although the underlying causes of IBD remain largely undefined, the fundamental defect involves a loss of intestinal epithelial barrier function. Furthermore, IBD is a condition that also greatly increases the risk of colorectal cancer (CRC).Importantly, these inflamed and/or tumor sites are hypoxic relative to normal healthy tissue, and it has been shown before that this condition can be detrimental to the final outcome of the disease. Central players in these complex processes are the HIF prolyl hydroxylases (PHDs); oxygen sensors that have not only been shown to regulate hypoxia inducible factor (HIFs), but also interfere in the NFkB and TGFb pathway. Although it has been demonstrated that general PHD-inhibition can be protective in a mouse model of dextran sodium sulphate (DSS)-induced IBD, our preliminary data strongly suggest that mice deficient for PHD2 in different cell lineages are much more susceptible than their WT littermates.With this project we propose to unravel the cellular and molecular background of this sensitivity. Therefore, we will make use of our unique collection of different single and double conditional knock-out mice (PHD2/HIFas) that we developed during the Emmy Noether program or mice obtained through fruitful collaborations (EPO-Tg6). Next to HIF, as the main downstream mediator, we will also focus on the other aforementioned pathways using different in vivo and ex vivo approaches.In a model of chemically/inflammatory induced CRC (AOM/DSS), we were able to detect reduced tumor development in mice lacking PHD2 in their intestinal epithelial cells. The results of these initial experiments are in line with our earlier findings showing the pro-tumoral nature of the enzyme. The second line of this project will therefore be focused on the unraveling of the PHD2 effect during tumor initiation and propagation.Moreover, in view of the interdisciplinary research collaboration we plan to develop during the Heisenberg program (please see the Heisenberg application for details), we will also be able to use an impressive collection of samples from patients with ulcerative colitis and colitis-associated dysplasia and cancer. Thus, this will give us the opportunity to link our findings in the different mouse models to colon-related pathologies in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of hypoxia pathway proteins in hematopoiesis and inflammation
-
批准号:418870769
-
项目类别:Heisenberg Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Ben Wielockx, Ph.D.
-
依托单位:
The impact of endothelial restricted hypoxia pathway proteins (PHD2 and endoglin) on the hematopoietic system and its bone marrow niche
-
批准号:418871341
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Ben Wielockx, Ph.D.
-
依托单位:
HIF-pathway proteins during physiological and pathological processes in mice
-
批准号:244794751
-
项目类别:Heisenberg Professorships
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Ben Wielockx, Ph.D.
-
依托单位:
The role of HIF prolyl hydroxylase-2 (PHD2) during physiological and pathological processes in mice
-
批准号:35183441
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Ben Wielockx, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
miR-30c-5p通过MTDH/HIF-1α/PKM2环形反馈抑制乳腺癌进展的作用及机制研究
-
批准号:JCZRLH202600025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α-FtL信号轴通过调控神经元铁稳态抑制NLRP3炎性小体活化在脑缺血再灌注损伤中的作用与机制研究
-
批准号:JCZRLH202600706
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肿瘤相关成纤维细胞通过分泌COL10A1 介导HIF1α/KLF5调控肝细胞癌上皮间质转化和血管生成拟态的机制研究
-
批准号:JCZRLH202602031
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α介导H3K18乳酸化调控石榴皮多酚改善痤疮皮脂代谢紊乱机制研究
-
批准号:2026JJ60632
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王云
-
依托单位:
HIF1-α/PKM2调控糖酵解-STING组蛋白乳酸化介导小胶质细胞训练免疫在应激性认知功能障碍中的作用及机制
-
批准号:2026JJ50024
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭思杰
-
依托单位:
基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
-
批准号:2026JJ80362
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周新
-
依托单位:
糖尿病肾病肾纤维化改善新机制:SIRT3/HIF-1α维持足细胞脂代谢抑制细胞焦亡
-
批准号:2026JJ82303
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘润芝
-
依托单位:
降脂消斑片通过HIF-1α/PKM2信号通路介导的能量代谢重编程抑制巨噬细胞铁死亡治疗动脉粥样硬化的作用机制
-
批准号:2026JJ60305
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张杼惠
-
依托单位:
基于HIF-1αVEGFMMPs信号通路研究经筋弹拨法改善KOA大鼠骨破坏的研究
-
批准号:2026JJ80645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡金鲁
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位: